Biomarkers are hardly new. Standard tests to ascertain blood pressure or cholesterol levels are only conducted because they are useful as indicators of the existence or progression of disease. What is new is the urgent need for cheaper and more effective ways of developing drugs, coupled ...
Clinica
The search for novel endpoints
18 December 2009
Jacky Law
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
Other Informa News
EVENTS
17 November 2010
London, UK
